Chuncao Xu

543 total citations
12 papers, 315 citations indexed

About

Chuncao Xu is a scholar working on Molecular Biology, Cancer Research and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Chuncao Xu has authored 12 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Chuncao Xu's work include Cancer, Lipids, and Metabolism (3 papers), RNA modifications and cancer (2 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Chuncao Xu is often cited by papers focused on Cancer, Lipids, and Metabolism (3 papers), RNA modifications and cancer (2 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Chuncao Xu collaborates with scholars based in China, Macao and Australia. Chuncao Xu's co-authors include Min Huang, Jing Jin, Wei‐Bang Yu, Di Cao, Zhongxiang Zhao, Zhongxiang Zhao, Jing Jin, Xupeng Bai, Yibei Chen and Xiaolei Zhang and has published in prestigious journals such as Journal of Ethnopharmacology, Psychopharmacology and European Journal of Pharmacology.

In The Last Decade

Chuncao Xu

11 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chuncao Xu China 10 169 80 45 37 35 12 315
Jiake He China 12 149 0.9× 51 0.6× 28 0.6× 74 2.0× 34 1.0× 31 411
Wei‐Bang Yu China 11 161 1.0× 44 0.6× 27 0.6× 27 0.7× 37 1.1× 15 402
Ling Huang China 13 184 1.1× 58 0.7× 24 0.5× 24 0.6× 54 1.5× 49 473
Wensong Zhang China 10 228 1.3× 41 0.5× 11 0.2× 21 0.6× 51 1.5× 22 461
Wenbin Xu China 10 113 0.7× 45 0.6× 22 0.5× 24 0.6× 19 0.5× 19 316
Fang Cheng Wong Singapore 9 210 1.2× 74 0.9× 16 0.4× 22 0.6× 19 0.5× 12 393
Mervat M. Omran Egypt 12 113 0.7× 31 0.4× 20 0.4× 40 1.1× 14 0.4× 42 365
Mohamed Hessien Egypt 12 189 1.1× 44 0.6× 21 0.5× 41 1.1× 29 0.8× 31 361
Hui Bi China 10 125 0.7× 27 0.3× 19 0.4× 21 0.6× 24 0.7× 33 395

Countries citing papers authored by Chuncao Xu

Since Specialization
Citations

This map shows the geographic impact of Chuncao Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuncao Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuncao Xu more than expected).

Fields of papers citing papers by Chuncao Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuncao Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuncao Xu. The network helps show where Chuncao Xu may publish in the future.

Co-authorship network of co-authors of Chuncao Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Chuncao Xu. A scholar is included among the top collaborators of Chuncao Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuncao Xu. Chuncao Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Xu, Chuncao, Cheng Qian, Yanming Zhang, et al.. (2025). Ginsenoside Rh2 in combination with IFNγ potentiated the anti-cancer effect by enhancing interferon signaling response in colorectal cancer cells. Acta Pharmacologica Sinica. 46(9). 2534–2546.
2.
Zhang, Lei, Chuncao Xu, Junyuan Huang, et al.. (2024). Tanshinone IIA reverses gefitinib resistance in EGFR‐mutant lung cancer via inhibition of SREBP1‐mediated lipogenesis. Phytotherapy Research. 38(3). 1574–1588. 4 indexed citations
3.
Xu, Chuncao, Yifan Lin, Xiaolei Zhang, et al.. (2023). Paraptosis: a non-classical paradigm of cell death for cancer therapy. Acta Pharmacologica Sinica. 45(2). 223–237. 38 indexed citations
4.
Xu, Chuncao, Lei Zhang, Shiqin Jiang, et al.. (2021). Lipidomics reveals that sustained SREBP-1-dependent lipogenesis is a key mediator of gefitinib-acquired resistance in EGFR-mutant lung cancer. Cell Death Discovery. 7(1). 353–353. 34 indexed citations
5.
Cao, Lin, Chuncao Xu, Xupeng Bai, et al.. (2020). Cryptotanshinone strengthens the effect of gefitinib against non-small cell lung cancer through inhibiting transketolase. European Journal of Pharmacology. 890. 173647–173647. 20 indexed citations
6.
7.
8.
Yu, Wei‐Bang, et al.. (2018). Simultaneous determination of trimethylamine N -oxide, choline, betaine by UPLC–MS/MS in human plasma: An application in acute stroke patients. Journal of Pharmaceutical and Biomedical Analysis. 152. 179–187. 30 indexed citations
9.
Xu, Chuncao, Di Cao, Wei‐Bang Yu, et al.. (2018). Inhibition of Glucose-6-Phosphate Dehydrogenase Reverses Cisplatin Resistance in Lung Cancer Cells via the Redox System. Frontiers in Pharmacology. 9. 43–43. 49 indexed citations
10.
Cao, Di, Chuncao Xu, Yuanyuan Xue, et al.. (2018). The therapeutic effect of Ilex pubescens extract on blood stasis model rats according to serum metabolomics. Journal of Ethnopharmacology. 227. 18–28. 27 indexed citations
11.
Zhang, Qian, Chuncao Xu, Shiqi Lin, et al.. (2018). Synergistic immunoreaction of acupuncture-like dissolving microneedles containing thymopentin at acupoints in immune-suppressed rats. Acta Pharmaceutica Sinica B. 8(3). 449–457. 30 indexed citations
12.
Bai, Xupeng, Yibei Chen, Chuncao Xu, et al.. (2017). Valproate induced hepatic steatosis by enhanced fatty acid uptake and triglyceride synthesis. Toxicology and Applied Pharmacology. 324. 12–25. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiake He Breakdown of academic impact, for papers by Wei‐Bang Yu Breakdown of academic impact, for papers by Ling Huang Breakdown of academic impact, for papers by Wensong Zhang Breakdown of academic impact, for papers by Wenbin Xu Breakdown of academic impact, for papers by Fang Cheng Wong Breakdown of academic impact, for papers by Mervat M. Omran Breakdown of academic impact, for papers by Mohamed Hessien Breakdown of academic impact, for papers by Hui Bi
Rankless by CCL
2026